Skip to search formSkip to main contentSkip to account menu

OK-432

Known as: Streptococcal OK 432, Streptococcal OK432, 432 ok 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
A lipoteichoic acid-related molecule OK-PSA is an active component of OK-432, a Streptococcus-derived anticancer… 
Highly Cited
2003
Highly Cited
2003
BACKGROUND The streptococcal agent OK-432 has been used for immunotherapy of head and neck cancer, among other malignancies, but… 
2003
2003
Abstract. A 36-year-old man was admitted who had a 2-month history of swelling of the right submandibular area and the right side… 
2003
2003
A 36-year-old multiparous woman was referred at 25 weeks of gestation with suspected cystic hygroma. Ultrasonographic examination… 
2001
2001
We present a case of pleurodesis by intrapleural injection of OK‐432 for the treatment of fetal chylothorax at an early… 
Highly Cited
2001
Highly Cited
2001
A 38‐year‐old multiparous woman was referred at 19 weeks' gestation because of hydrops fetalis. Ultrasonic examination revealed… 
Review
1993
Review
1993
1. The immunomodulating activity of antifungal drugs was reviewed. Although results are conflicting, all azole drugs tend to be… 
Highly Cited
1984
Highly Cited
1984
Mouse spleen cells, either pretreated in vitro with 100 U/ml of OK‐432‐induced IFN gamma for 18 h or obtained from mice 24 or 48… 
Highly Cited
1981
Highly Cited
1981
The characteristics of the cytotoxic cells induced by ip injections of an immunoadjuvant, OK-432 (Picibanil), into ACI/N rats… 
Highly Cited
1976
Highly Cited
1976
Streptococcal agent OK‐432 was administered at maintenance levels with conventional inductive chemotherapeutic agents to stage…